Skip to content

Clinical trials

Phase 2 Atrial Fibrillation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 2 Clear all

134 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20041
20058
20068
20078
20089
20095
20106
201110
20128
20138
20147
20151
20164
20174
20184
20195
20204
20215
20224
20231
20245
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed80
Unknown status19
Recruiting12
Terminated12
Withdrawn5
Active, not recruiting5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Meshalkin Research Institute of Pathology of Circulation15
Bayer6
AtriCure, Inc.4
GlaxoSmithKline4
AstraZeneca3
Boehringer Ingelheim3
Hamilton Health Sciences Corporation3
Novartis Pharmaceuticals3
Sequel Pharmaceuticals, Inc3
ARYx Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation134
Stroke10
Atrial Flutter8
Arrhythmias, Cardiac7
Heart Failure4
Hypertension4
Thromboembolism4
Venous Thromboembolism4
Cardiovascular Diseases3
Cerebral Hemorrhage2

Trials

Showing 1 to 25 of 134. Each trial links to its page on Pharma Observatory.

34 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.